Grapevine: True North-backed Anthem Bio mulls IPO; CVC Capital India head resigns

Premium

Anthem Biosciences Pvt Ltd, a Bengaluru-based contract drug researcher and manufacturer, is contemplating an initial public offering (IPO) in India that could raise about $400 million (Rs 3340 crore), a media report said.   VCCircle first reported that Anthem is looking to snag $50-70 million in fresh funding as it gears up for an IPO.   Indian private equity ......